Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mander

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 18, 2011
Reducing sample sizes in two-stage phase II cancer trials by using continuous tumour shrinkage end-pointsJames M S Wason, Adrian P Mander, Tim G Eisen
Statistics in Medicine|December 6, 2011
Optimal multistage designs for randomised clinical trials with continuous outcomesJames M S Wason, Adrian P Mander, Simon G Thompson
Communications in Statistics: Theory and Methods|January 7, 2021
Exact group sequential designs for two-arm experiments with Poisson distributed outcome variablesMichael J Grayling, James M S Wason, Adrian P Mander
The Stata Journal|February 7, 2022
Group sequential clinical trial designs for normally distributed outcome variablesMichael J Grayling, James M S Wason, Adrian P Mander
Contemporary Clinical Trials|February 24, 2018
An optimised multi-arm multi-stage clinical trial design for unknown varianceMichael J Grayling, James M S Wason, Adrian P Mander
Sequential Analysis|November 6, 2018
Group sequential crossover trial designs with strong control of the familywise error rateMichael J Grayling, James M S Wason, Adrian P Mander
Trials|January 23, 2017
Stepped wedge cluster randomized controlled trial designs: a review of reporting quality and design featuresMichael J Grayling, James M S Wason, Adrian P Mander
Journal of the National Cancer Institute|June 21, 2019
A Review of Perspectives on the Use of Randomization in Phase II Oncology TrialsMichael J Grayling, Munyaradzi Dimairo, Adrian P Mander, et al.
Neuroscience|March 8, 2002
Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegenerationM M Iravani, K Kashefi, P Mander, et al.
Statistics in Medicine|October 16, 1999
Autoregressive models for describing non-linear changes in biological parameters fitted using BUGSA P Mander, M D Hughes, S J Sharp, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|January 18, 2011
Reducing sample sizes in two-stage phase II cancer trials by using continuous tumour shrinkage end-pointsJames M S Wason, Adrian P Mander, Tim G Eisen
Statistics in Medicine|December 6, 2011
Optimal multistage designs for randomised clinical trials with continuous outcomesJames M S Wason, Adrian P Mander, Simon G Thompson
Communications in Statistics: Theory and Methods|January 7, 2021
Exact group sequential designs for two-arm experiments with Poisson distributed outcome variablesMichael J Grayling, James M S Wason, Adrian P Mander
The Stata Journal|February 7, 2022
Group sequential clinical trial designs for normally distributed outcome variablesMichael J Grayling, James M S Wason, Adrian P Mander
Contemporary Clinical Trials|February 24, 2018
An optimised multi-arm multi-stage clinical trial design for unknown varianceMichael J Grayling, James M S Wason, Adrian P Mander
Sequential Analysis|November 6, 2018
Group sequential crossover trial designs with strong control of the familywise error rateMichael J Grayling, James M S Wason, Adrian P Mander
Trials|January 23, 2017
Stepped wedge cluster randomized controlled trial designs: a review of reporting quality and design featuresMichael J Grayling, James M S Wason, Adrian P Mander
Journal of the National Cancer Institute|June 21, 2019
A Review of Perspectives on the Use of Randomization in Phase II Oncology TrialsMichael J Grayling, Munyaradzi Dimairo, Adrian P Mander, et al.
Neuroscience|March 8, 2002
Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegenerationM M Iravani, K Kashefi, P Mander, et al.
Statistics in Medicine|October 16, 1999
Autoregressive models for describing non-linear changes in biological parameters fitted using BUGSA P Mander, M D Hughes, S J Sharp, et al.
Pageof 9